HSDL2 Acts as a Promoter in Pancreatic Cancer by Regulating Cell Proliferation and Lipid Metabolism

References

• Long J, Luo GP, Xiao ZW, et al. Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China. Cancer Lett. 2014;346(2):273–277. doi:10.1016/j.canlet.2014.01.004
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Duax WL, Ghosh D. Structure and function of steroid dehydrogenases involved in hypertension, fertility, and cancer. Steroids. 1997;62(1):95–100. doi:10.1016/S0039-128X(96)00166-3
   PubMed Web of Science ®Google Scholar
• Oppermann UC, Salim S, Tjernberg LO, et al. Binding of amyloid beta-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer’s disease. FEBS Lett. 1999;451(3):238–242. doi:10.1016/S0014-5793(99)00586-4
   PubMed Web of Science ®Google Scholar
• Gallegos AM, Atshaves BP, Storey SM, et al. Gene structure, intracellular localization, and functional roles of sterol carrier protein-2. Prog Lipid Res. 2001;40(6):498–563. doi:10.1016/S0163-7827(01)00015-7
   PubMed Web of Science ®Google Scholar
• Seedorf U, Ellinghaus P, Nofer JR. Sterol carrier protein-2. Biochim Biophys Acta. 2000;1486(1):45–54. doi:10.1016/S1388-1981(00)00047-0
   PubMed Web of Science ®Google Scholar
• Chanderbhan RF, Kharroubi AT, Noland BJ, et al. Sterol carrier protein 2: further evidence for its role in adrenal steroidogenesis. Endocr Res. 1986;12(4):351–370. doi:10.3109/07435808609035445
   PubMed Web of Science ®Google Scholar
• Dai J, Xie Y, Wu Q, et al. Molecular cloning and characterization of a novel human hydroxysteroid dehydrogenase-like 2 (HSDL2) cDNA from fetal brain. Biochem Genet. 2003;41(5–6):165–174. doi:10.1023/A:1023377627138
   PubMed Web of Science ®Google Scholar
• Ruokun C, Yake X, Fengdong Y, et al. Lentivirus-mediated silencing of HSDL2 suppresses cell proliferation in human gliomas. Tumour Biol. 2016;37(11):15065–15077. doi:10.1007/s13277-016-5402-6
   PubMedGoogle Scholar
• Kowalik D, Haller F, Adamski J, Moeller G. In search for function of two human orphan SDR enzymes: hydroxysteroid dehydrogenase like 2 (HSDL2) and short-chain dehydrogenase/reductase-orphan (SDR-O). J Steroid Biochem Mol Biol. 2009;117(4–5):117–124. doi:10.1016/j.jsbmb.2009.08.001
   PubMed Web of Science ®Google Scholar
• Shi Y, Mao Z, Huang Y, et al. Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression. Biosci Rep. 2020;40(4):BSR20200348. doi:10.1042/BSR20200348
   PubMedGoogle Scholar
• Jia LH, Hu MD, Liu Y, et al. HSDL2 promotes bladder cancer growth in vitro and in vivo. Int J Med Sci. 2019;16(5):654–659. doi:10.7150/ijms.31288
   PubMed Web of Science ®Google Scholar
• Sun Q, Zhang Y, Su J, et al. Role of hydroxysteroid dehydrogenase-like 2 (HSDL2) in human ovarian cancer. Med Sci Monit. 2018;24:3997–4008. doi:10.12659/MSM.909418
   PubMed Web of Science ®Google Scholar
• Liu Y. Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer Prostatic Dis. 2006;9(3):230–234. doi:10.1038/sj.pcan.4500879
   PubMed Web of Science ®Google Scholar
• Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell. 2008;13(6):472–482. doi:10.1016/j.ccr.2008.05.005
   PubMed Web of Science ®Google Scholar
• Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 2000;16(3):202–208. doi:10.1016/S0899-9007(99)00266-X
   PubMed Web of Science ®Google Scholar
• Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care. 2006;9(4):358–365. doi:10.1097/01.mco.0000232894.28674.30
   PubMed Web of Science ®Google Scholar
• Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7(10):763–777. doi:10.1038/nrc2222
   PubMed Web of Science ®Google Scholar
• Lee JH, Cho YR, Kim JH, et al. Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolism. Exp Mol Med. 2019;51(11):1–11. doi:10.1038/s12276-019-0299-y
   Google Scholar
• Zeng J, Ma X, Wang J, et al. Down-regulated HSDL2 expression suppresses cell proliferation and promotes apoptosis in papillary thyroid carcinoma. Biosci Rep. 2019;39(6):BSR20190425. doi:10.1042/BSR20190425
   PubMedGoogle Scholar
• Dong B, Yang Y, Han A, et al. Ectopic expression of HSDL2 is related to cell proliferation and prognosis in breast cancer. Cancer Manag Res. 2019;11:6531–6542. doi:10.2147/CMAR.S205316
   PubMed Web of Science ®Google Scholar
• Howard BV, Morris HP, Bailey JM. Ether-lipids, -glycerol phosphate dehydrogenase, and growth rate in tumors and cultured cells. Cancer Res. 1972;32(7):1533–1538.
   PubMed Web of Science ®Google Scholar
• Falomir Lockhart LJ, Burgardt NI, Ferreyra RG, et al. Fatty acid transfer from Yarrowia lipolytica sterol carrier protein 2 to phospholipid membranes. Biophys J. 2009;97(1):248–256. doi:10.1016/j.bpj.2009.03.063
   PubMed Web of Science ®Google Scholar
• Hillard CJ, Huang H, Vogt CD, et al. Endocannabinoid transport proteins: discovery of tools to study sterol carrier protein-2. Methods Enzymol. 2017;593:99–121.
   PubMed Web of Science ®Google Scholar
• Wüstner D, Solanko K. How cholesterol interacts with proteins and lipids during its intracellular transport. Biochim Biophys Acta. 2015;1848(9):1908–1926. doi:10.1016/j.bbamem.2015.05.010
   PubMed Web of Science ®Google Scholar
• Singarapu KK, Ahuja A, Potula PR, Ummanni R. Solution nuclear magnetic resonance studies of sterol carrier protein 2 like 2 (SCP2L2) reveal the insecticide specific structural characteristics of SCP2 proteins in aedes aegypt mosquitoes. Biochemistry. 2016;55(35):4919–4927. doi:10.1021/acs.biochem.6b00322
   PubMed Web of Science ®Google Scholar
• Seidel G, Prohaska R. Molecular cloning of hSLP-1, a novel human brain-specific member of the band 7/MEC-2 family similar to Caenorhabditis elegans UNC-24. Gene. 1998;225(1–2):23–29. doi:10.1016/S0378-1119(98)00532-0
   PubMed Web of Science ®Google Scholar
• Oppermann UC, Filling C, Jörnvall H. Forms and functions of human SDR enzymes. Chem Biol Interact. 2001;130–132(1–3):699–705. doi:10.1016/S0009-2797(00)00301-X
   PubMed Web of Science ®Google Scholar
• Aube JM, Klein A, Brahmer JR, et al. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin Cancer Res. 2014;20(19):5064–5074. doi:10.1158/1078-0432.CCR-13-3271
   PubMed Web of Science ®Google Scholar
• Baker ME. Evolution of 17beta-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action. Mol Cell Endocrinol. 2001;171(1–2):211–215. doi:10.1016/S0303-7207(00)00414-7
   PubMed Web of Science ®Google Scholar
• Zhang DY, Liu Z, Lu Z, et al. Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma. Onco Targets Ther. 2018;11:7133–7142. doi:10.2147/OTT.S176410
   PubMed Web of Science ®Google Scholar